HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $7 price target.